(NYSE: LLY) Eli Lilly & Co's forecast annual revenue growth rate of 19.7% is forecast to beat the US Drug Manufacturers - General industry's average forecast revenue growth rate of 7.16%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.54%.
Eli Lilly & Co's revenue in 2025 is $49,003,200,000.On average, 7 Wall Street analysts forecast LLY's revenue for 2025 to be $56,740,696,491,457, with the lowest LLY revenue forecast at $55,508,877,079,070, and the highest LLY revenue forecast at $59,116,447,050,636. On average, 7 Wall Street analysts forecast LLY's revenue for 2026 to be $68,674,937,314,247, with the lowest LLY revenue forecast at $64,623,250,834,737, and the highest LLY revenue forecast at $74,905,054,842,662.
In 2027, LLY is forecast to generate $79,455,079,682,181 in revenue, with the lowest revenue forecast at $74,054,168,297,838 and the highest revenue forecast at $87,528,466,285,204.